Barbiturates, Umbilical Cord Tissue
Use
This test detects barbiturates in umbilical cord tissue as part of neonatal drug exposure screening. It is intended to provide evidence of in‑utero exposure to barbiturates via analysis of neonatal tissue at birth. Confirmation testing will be performed when appropriate, at no additional charge.
Special Instructions
Only orderable as part of the Comprehensive Drug Screen, Umbilical Cord Tissue (FCDSU) profile. Reporting name is “Barbiturates, UC.” NY State approval is “Yes.”
Limitations
Results rely on suitability of submitted tissue specimens, which will be evaluated by the performing laboratory. Reporting limits are determined per analysis.
New York Approved
Methodology
Mass Spectrometry (LC-MS/MS)
Biomarkers
LOINC Codes
- 97300-8
- 97224-0
Result Turnaround Time
3-7 days
Related Documents
For more information, please review the documents below
Specimen
Tissue
Volume
Not provided
Minimum Volume
Not provided
Causes for Rejection
All specimens will be evaluated by the processing and performing laboratories for test suitability.
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 7 days |
| Frozen | 14 days |